Executive Summary
An unprecedented 34 Form 8-K filings reporting executive and director changes under Item 5.02 were submitted on January 21, 2026, spanning diverse industries including tech, biotech, energy, consumer goods, and industrials, marking a sharp spike in leadership event disclosures. All events carry neutral sentiment with low-to-medium materiality (average 3/10) due to uniform absence of critical details such as officer positions, names, resignation/appointment status, or reasons, limiting immediate directional assessment. This volume suggests potential batch reporting, year-start governance realignments, or systemic pressures, with low cumulative market impact absent follow-on details but warranting vigilance for emerging patterns in leadership stability.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 19, 2026.
Investment Signals(5)
- CompoSecure, Inc. (CMPO)↓(BULLISH POTENTIAL)▲
Potential strong succession planning or expertise addition pending full review
- Dave Inc. (DAVE)(NEUTRAL TO BULLISH)▲
Higher materiality officer change could signal strategic leadership refresh
- Oportun Financial Corp (OPRT)↓(BULLISH POTENTIAL)▲
Possible internal promotion amid financial disclosure context
- MSC Industrial Direct Co Inc (MSM)↓(NEUTRAL)▲
Officer change paired with shareholder vote may indicate stable governance evolution
- McCormick & Co Inc (MKC)↓(NEUTRAL)▲
Routine disclosure in consumer staples unlikely to materially impact operations
Risk Flags(4)
- Multiple Filings/Governance Opacity▼
34 events lack officer details, reasons, or positions, obscuring potential instability or performance issues
Medium-risk tech change without context amid cybersecurity sector pressures
- Biotech Cluster (Galectin, Celularity, AEON, ALX)/Talent Risk▼
Multiple biotech filings signal possible sector-wide executive churn
Item 3.02 equity sales alongside officer change raises dilution and governance concerns
Opportunities(4)
Higher materiality event offers alpha if details reveal expertise upgrade in fintech
Item 2.02 results paired with change could highlight undervalued leadership transition
Multi-item filing (5.02+5.03) may uncover bylaws-strengthening moves for M&A appeal
- Biotech Names (Galectin, ALX)/Turnover Arbitrage◆
Cluster of changes positions for short-term trading on detail revelations
Sector Themes(3)
- Widespread Governance Refresh◆
34 same-day filings across sectors imply broad executive realignment, potentially signaling post-2025 economic adjustments with neutral portfolio impact
- Detail Deficiency Pattern◆
Uniform lack of specifics (names, reasons) across tech, biotech, energy correlates with medium risk, creating information asymmetry for early detail access
- Multi-Item Filing Correlation◆
~70% include Reg FD (7.01) or exhibits (9.01), hinting at compensatory or strategic disclosures that could cluster into sector leadership trends
Watch List(4)
Highest materiality (5/10); monitor for CFO/CEO details and stock reaction
Financial results (Item 2.02) context may amplify officer change impact
Cybersecurity leader; track for implications on growth execution
- Biotech Cluster (Galectin Therapeutics, Celularity, ALX Oncology)👁
Volume suggests sector stress; watch Q1 performance
Filing Analyses(34)
21-01-2026
CompoSecure, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0000950142-26-000205, Size: 397 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position, appointment/resignation status, reasons, or any quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
21-01-2026
Company filed an 8-K on January 21, 2026 (AccNo: 0001140361-26-001872, Size: 288 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, title, reason for change, or other quantitative data are provided in the filing summary. Sector is not specified.
21-01-2026
Galectin Therapeutics Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001140361-26-001866, Size: 154 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons, or nature of change (appointment or resignation) are stated.
21-01-2026
Zeo ScientifiX, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001829126-26-000431, Size: 183 KB) disclosing an officer change under Item 5.02, which covers departures or appointments of directors or certain officers, or compensatory arrangements. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are provided in the filing summary. This event is classified as NEUTRAL with no directional investment bias due to lack of disclosed facts.
21-01-2026
Getty Realty Corp (/MD/) filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-018169, Size: 165 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, appointment or resignation status, reasons for change, named individuals, or any quantitative data are NOT_DISCLOSED. Event type is Officer Change from US SEC source; sector not specified.
21-01-2026
LSB Industries, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-016955, Size: 469 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or quantitative impacts are provided; sector not specified.
21-01-2026
SentinelOne, Inc. disclosed an officer change event under Item 5.02 of Form 8-K filed on January 21, 2026 (AccNo: 0001583708-26-000006, Size: 151 KB). The filing pertains to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the available information.
21-01-2026
Dave Inc./DE filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-016910, Size: 246 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or other quantitative data are provided in the filing summary. Sector is not specified.
21-01-2026
GE Vernova Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001996810-26-000004, Size: 143 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the officer, position, reason for change, or compensatory arrangements are provided in the available summary. Sector is not specified.
21-01-2026
DAKTRONICS INC /SD/ filed an 8-K on January 21, 2026 (AccNo: 0001628280-26-002798, Size: 329 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
21-01-2026
Five9, Inc. disclosed an officer change via Form 8-K filed on January 21, 2026 (AccNo: 0001288847-26-000006, Size: 9 MB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, nature of change, reasons, or compensation are provided.
21-01-2026
MANITOWOC CO INC filed an 8-K on January 21, 2026 (AccNo: 0001193125-26-017317, Size: 295 KB) disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided in the summary. Sector is not specified.
21-01-2026
Acorn Energy, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001493152-26-003005, Size: 210 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including key position affected, appointment/resignation status, reasons, named individuals, or quantitative data are NOT_DISCLOSED. Event type is Officer Change; sector not specified.
21-01-2026
Foxx Development Holdings Inc. disclosed an officer change via SEC Form 8-K filed on January 21, 2026 (AccNo: 0001213900-26-005933, Size: 339 KB), under Item 5.02 covering departures or elections of directors/officers and compensatory arrangements, with Item 9.01 for financial statements and exhibits. No specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data are provided. Sector is not specified.
21-01-2026
Orion Bliss Corp. filed an 8-K on January 21, 2026 (AccNo: 0001683168-26-000443, Size: 187 KB), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
21-01-2026
Company filed Form 8-K on January 21, 2026 (AccNo: 0001304280-26-000002, Size: 136 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on officer names, positions, reasons for change, or quantitative data provided in the filing summary.
21-01-2026
MSC Industrial Direct Co Inc filed an 8-K on January 21, 2026 (AccNo: 0001003078-26-000017, Size: 198 KB), disclosing Item 5.02 on Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, Item 5.07 on Submission of Matters to a Vote of Security Holders, and Item 9.01 on Financial Statements and Exhibits. No specific details on officers, reasons for changes, vote outcomes, or exhibits are stated. Sector not specified.
21-01-2026
McCormick & Co Inc filed a Form 8-K on January 21, 2026 (AccNo: 0000063754-26-000031, Size: 730 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual, reason for change, or type (appointment/resignation) are disclosed. Sector is not specified.
21-01-2026
Simply Good Foods Co disclosed an officer change via Form 8-K filed on January 21, 2026 (AccNo: 0001104659-26-005379, Size: 635 KB). Items include 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, or reasons provided.
21-01-2026
Celularity Inc filed a Form 8-K on 2026-01-21 (AccNo: 0001493152-26-003100, Size: 250 KB) under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, internal/external status, or compensation are provided. Sector is not specified.
21-01-2026
Universal Corp /VA/ filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-018019, size 185 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reason, or any quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided summary. Sector is not specified.
21-01-2026
SITIME Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001451809-26-000003, Size: 214 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, nature of change, reasons, or quantitative data are provided.
21-01-2026
Oportun Financial Corp filed an 8-K on 2026-01-21 (AccNo: 0001193125-26-017944, Size: 331 KB) disclosing an officer change under Item 5.02, along with results of operations and financial condition (Item 2.02) and financial statements/exhibits (Item 9.01). Event type is Officer Change dated January 21, 2026, sourced from US SEC. No specific details on the officer, position, appointment/resignation, or reasons provided in the summary.
21-01-2026
AEON Biopharma, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001837607-26-000005, Size: 447 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). The filing also covers Item 3.02 (Unregistered Sales of Equity Securities), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, reason for change, or quantitative impacts are disclosed.
21-01-2026
Permian Resources Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001658566-26-000025, Size: 142 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual names, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified, limiting assessment of governance or market implications.
21-01-2026
New York Times Co filed an 8-K on January 21, 2026 (AccNo: 0000071691-26-000003, Size: 438 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment/resignation), reasons, or quantitative data are provided. Sector is not specified.
21-01-2026
First American Financial Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-017981, Size: 148 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, appointment/resignation, or reasons are provided in the summary.
21-01-2026
Appian Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001441683-26-000003, Size: 160 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or other outcomes are provided in the available information. Sector not specified.
21-01-2026
AmBase Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001140361-26-001845, Size: 135 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific names, positions, reasons, or quantitative details provided in the filing summary.
21-01-2026
Teledyne Technologies Inc filed an 8-K on January 21, 2026 (AccNo: 0001094285-26-000010, Size: 187 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
21-01-2026
Phoenix Energy One, LLC filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-018050, Size: 249 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or compensation are disclosed in the provided filing summary. Sector is not specified.
21-01-2026
The company filed a Form 8-K on January 21, 2026 (AccNo: 0001104659-26-005380, Size: 251 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Event type is Officer Change with date January 21, 2026; no specific details on position, person, reason, or type provided. Sector not specified; all quantitative data, names, and further details NOT_DISCLOSED.
21-01-2026
PUBLIC SERVICE ENTERPRISE GROUP INC filed an 8-K on January 21, 2026 (AccNo: 0001193125-26-018045), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
21-01-2026
ALX Oncology Holdings Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-018094, Size: 705 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. Sector is not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 34 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings